JAMA Oncology Author Interviews

JAMA Oncology Author Interviews

Por: JAMA Network
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
129 episodios disponibles

Latest episodes of the podcast JAMA Oncology Author Interviews

Mostrando página 4 de 7

Tailoring Intensity of Surveillance for Prostate Cancer Based on Prediction of Risk Stability 27/08/2020
Presence of ctDNA and CTCs After Chemotherapy and Recurrence of Triple-Negative Breast Cancer 09/07/2020
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults 18/06/2020
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases 04/06/2020
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer 16/04/2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy for Metastatic NSCLC 09/04/2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer 13/02/2020
Cost Transparency for Prostate Cancer Radiation Therapy at National Cancer Institute–Designated Cancer Centers 16/01/2020
Association Between BMI and Overall Survival in Advanced Non–Small Cell Lung Cancer 26/12/2019
The Role of Maintenance Strategies in Metastatic Colorectal Cancer 19/12/2019
Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer 03/10/2019
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer 12/09/2019
Women's Representation Among Lead Investigators of Clinical Trials in Oncology 08/08/2019
Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab 25/07/2019
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers 27/06/2019
Prognostic Potential of Circulating Tumor DNA Measurement in Nonmetastatic Colorectal Cancer 09/05/2019
Single-Fraction Stereotactic vs Multifraction Radiotherapy for Pain Relief in Patients With Nonspine Bone Metastases 18/04/2019
The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms 21/03/2019
Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer 21/02/2019
Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation 10/01/2019
« Primera ‹ Anterior 1 2 3 4 5 6 7 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA